Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleInvited Perspective

Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?

Orazio Schillaci
Journal of Nuclear Medicine November 2014, 55 (11) 1757-1758; DOI: https://doi.org/10.2967/jnumed.114.147538
Orazio Schillaci
University of Rome Tor Vergata Viale G. Mazzini 121 Rome 00195, Italy E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: orazio.schillaci@uniroma2.it
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 55 no. 11 1757-1758
DOI 
https://doi.org/10.2967/jnumed.114.147538
PubMed 
25342386

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 26, 2014
  • Accepted for publication September 30, 2014
  • Published online November 3, 2014.

Article Versions

  • previous version (October 23, 2014 - 05:23).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Decoupled association between 18 F-FDG and 18 F-FDOPA uptake in a carcinoid of the thymus
    A. Chiaravalloti, O. Schillaci
    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2016 35 2
  • Decoupled association between 18F-FDG and 18F-FDOPA uptake in a carcinoid of the thymus
    A. Chiaravalloti, O. Schillaci
    Revista Española de Medicina Nuclear e Imagen Molecular 2016 35 2

Article usage

Article usage: October 2014 to December 2022

AbstractFullPdf
Oct 20140049
Nov 20143148145
Dec 201441629
Jan 201511315
Feb 20154179
Mar 201501617
Apr 2015287
May 201503629
Jun 201501710
Jul 201511515
Aug 201501010
Sep 201512513
Oct 201511110
Nov 20150258
Dec 20150199
Jan 201612618
Feb 201623213
Mar 2016065
Apr 201601614
May 201601513
Jun 201602216
Jul 20160179
Aug 20162118
Sep 20161146
Oct 20160177
Nov 20161197
Dec 201622512
Jan 20172267
Feb 20171175
Mar 20171229
Apr 20172129
May 201732310
Jun 2017092
Jul 2017258
Aug 20170112
Sep 2017173
Oct 20172191
Nov 20173112
Dec 20172161
Jan 20182108
Feb 20180104
Mar 20181104
Apr 2018481
May 20181145
Jun 20181124
Jul 2018203
Aug 2018161
Sep 2018275
Oct 20182162
Nov 20182102
Dec 2018151
Jan 20192131
Feb 20192103
Mar 2019863
Apr 20195144
May 20197810
Jun 2019875
Jul 20194188
Aug 2019353
Sep 2019799
Oct 20195118
Nov 20194911
Dec 2019363
Jan 20204145
Feb 2020477
Mar 2020864
Apr 2020285
May 2020375
Jun 2020251
Jul 2020385
Aug 2020284
Sep 2020282
Oct 2020364
Nov 2020265
Dec 2020280
Jan 20210117
Feb 202101914
Mar 20210145
Apr 20210199
May 20210134
Jun 20210125
Jul 202101112
Aug 202101811
Sep 2021067
Oct 202101023
Nov 202101620
Dec 202102111
Jan 2022075
Feb 20220136
Mar 2022045
Apr 2022076
May 202201015
Jun 20220711
Jul 2022074
Aug 2022033
Sep 20220917
Oct 20220911
Nov 202202219
Dec 2022043
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (11)
Journal of Nuclear Medicine
Vol. 55, Issue 11
November 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
Orazio Schillaci
Journal of Nuclear Medicine Nov 2014, 55 (11) 1757-1758; DOI: 10.2967/jnumed.114.147538

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
Orazio Schillaci
Journal of Nuclear Medicine Nov 2014, 55 (11) 1757-1758; DOI: 10.2967/jnumed.114.147538
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field
  • Outcome of Patients with PSMA PET/CT Screening Failure by VISION Criteria and Treated with 177Lu-PSMA: A Multicenter Retrospective Analysis
  • 18F-FDG Uptake in Brown Adipose Tissue After Exposure to the Cold: From Possible Pitfall in Early PET Scans to Metabolic Biomarker
Show more Invited Perspective

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire